Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-07-30

FDA Approved: TRANDOLAPRIL — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Lupin Pharmaceuticals' supplemental application for trandolapril, enabling the marketing of a generic formulation. This action confirms regulat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trandolapril (trandolapril)

Snippet

SUPPL AP for TRANDOLAPRIL (TRANDOLAPRIL)